Skip to Content
Merck
CN
  • Emodin-mediated cross-linking enhancement for extracellular matrix homeostasis.

Emodin-mediated cross-linking enhancement for extracellular matrix homeostasis.

Biochemical and biophysical research communications (2014-04-01)
Lihua Jian, Chen Zhang, Guangfeng Chen, Xiujuan Shi, Yu Qiu, Yunyun Xue, Shuzhang Yang, Lixia Lu, Qionglan Yuan, Guotong Xu, Ming Ying, Xiaoqing Liu
ABSTRACT

The extracellular matrix (ECM) is an essential element of mammalian organisms, and its cross-linking formation plays a vital role in ECM development and postnatal homeostasis. Defects in cross-link formation caused by aging, genetic, or environmental factors are known to cause numerous diseases in mammals. To augment the cross-linking formation of ECM, the present study established a ZsGreen reporter system controlled by the promoter of lysyl oxidase-like 1 gene (LOXL1), which serves as both a scaffold element and a cross-linking enzyme in the ECM. By using this system in a drug screen, we identified emodin as a strong enhancer of LOXL1 expression that promoted cross-linking formation of ECM in all the tested systems, including human fibroblast cells, cultured human skin tissues, and animals that received long-term emodin treatment. Collectively, the results suggest that emodin may serve as an effective drug or supplement for ECM homeostasis.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
trans-4-Hydroxy-L-proline, BioXtra, ≥99.0% (NT)
Sigma-Aldrich
trans-4-Hydroxy-L-proline, ≥99%
Sigma-Aldrich
trans-4-Hydroxy-L-proline, BioReagent, suitable for cell culture, ≥98.5%
Supelco
trans-4-Hydroxy-L-proline, analytical standard
Sigma-Aldrich
trans-4-Hydroxy-L-proline, Vetec, reagent grade, 99%
Sigma-Aldrich
Emodin, from Frangula bark, ≥90% (HPLC)
Supelco
Emodin, analytical standard